Angel Lanas*, Yolanda Royo‡, Javier Ortego§, M. Molina*, R. Sáinz* 

Slides:



Advertisements
Similar presentations
Serum immunoglobulin a from patients with celiac disease inhibits human T84 intestinal crypt epithelial cell differentiation Tuula Halttunen, Markku Mäki.
Advertisements

Barrett's esophagus: photodynamic therapy for ablation of dysplasia, reduction of specialized mucosa, and treatment of superficial esophageal cancer 
Janusz A. Jankowski, Nick A. Wright, Stephen J
A rare case of extensive diffuse nonpigmented villonodular synovitis as a cause of total knee arthroplasty failure  Hacı Bayram Tosun, Abuzer Uludağ,
Volume 120, Issue 7, Pages (June 2001)
Volume 131, Issue 4, Pages (October 2006)
Alejandro Nieponice, MD, Thomas W. Gilbert, Stephen F
Immunopathological characterization of selected mouse models of inflammatory bowel disease: Comparison to human disease  Yava L. Jones-Hall, Matthew B.
Anti–tumor necrosis factor monoclonal antibody therapy for gastrointestinal Behçet's disease: A case report  Philip V. Hassard, Scott W. Binder, Viera.
Arnaldo B. Feitoza, MD, Christopher J. Gostout, MD, Lawrence J
International Journal of Surgery
Expression of acidic fibroblast growth factor in Barrett's esophagus and associated esophageal adenocarcinoma  Robert A. Soslow, MD, Liang Ying, BS, Nasser.
Endoscopy in eosinophilic esophagitis: “feline” esophagus and perforation risk  Mitchell Kaplan, Ece A. Mutlu, Shriram Jakate, Keith Bruninga, John Losurdo,
Volume 119, Issue 3, Pages (September 2000)
Volume 132, Issue 3, Pages (March 2007)
Volume 129, Issue 1, Pages (July 2005)
Volume 143, Issue 3, Pages e2 (September 2012)
Xiao-San Zhu, MM, Yi-Chen Dai, MD, Zhang-Xing Chen, MD 
Volume 129, Issue 5, Pages (November 2005)
Volume 137, Issue 5, Pages (November 2009)
Endoscopic Mucosal Resection in the Management of Esophageal Neoplasia: Current Status and Future Directions  Vikneswaran Namasivayam, Kenneth K. Wang,
Role of serotonin and nuclear factor-kappa B in the ameliorative effect of ginger on acetic acid-induced colitis  Eman S.H. Abd Allah, Rania Makboul,
Epithelial Cell Hyperproliferation After Biliopancreatic Reflux Into the Esophagus of Rats  Manuel Pera, Luis Grande, Marisa Gelabert, Xavier Figueras,
Volume 124, Issue 5, Pages (May 2003)
Volume 123, Issue 4, Pages (October 2002)
Volume 122, Issue 1, Pages (January 2002)
Volume 115, Issue 2, Pages (August 1998)
Maya Srivastava, Antonio Perez–Atayde, Maureen M. Jonas 
Mohammad M. Yousef, Rhonda K. Yantiss, Stephen P. Baker, Barbara F
Volume 115, Issue 4, Pages (October 1998)
The OARSI histopathology initiative – recommendations for histological assessments of osteoarthritis in the horse  C.W. McIlwraith, D.D. Frisbie, C.E.
Volume 132, Issue 3, Pages (March 2007)
K. Bielefeldt, N. Ozaki, G.F. Gebhart  Gastroenterology 
This month in Gastroenterology
A novel biomarker for the detection of esophageal adenocarcinoma
Elizabeth Montgomery, Marcia Irene Canto 
Volume 123, Issue 1, Pages (July 2002)
Volume 42, Issue 2, Pages (February 2005)
Shehzad Huda, Shabnum Chaudhery, Hassan Ibrahim, Arun Pramanik 
The normal configuration and interindividual differences in intramural lymphatic vessels of the esophagus  Shinji Yajin, MD, Gen Murakami, MD, PhD, Hiromi.
Clinical and immunopathologic effects of swallowed fluticasone for eosinophilic esophagitis  Richard J Noel, Philip E Putnam, Margaret H Collins, Amal.
Microscopic Esophageal Mucosal Injury in Nonerosive Reflux Disease
Eugene B. Chang  Gastroenterology  Volume 124, Issue 4, (April 2003)
Rapid development of colitis in NSAID-treated IL-10–deficient mice
Volume 120, Issue 4, Pages (March 2001)
Uptake and presentation of antigen to T cells by primary colonic epithelial cells in normal and diseased states  Grzegorz W. Telega, *,‡, Daniel C. Baumgart,
Perforating Barrett’s ulcer resulting in a life-threatening esophagobronchial fistula  John J Nigro, MD, MS, Ross M Bremner, MD, PhD, Clark B Fuller, MD,
Novel biodegradable polydioxanone stents in a rabbit airway model
A Mouse Model of Clostridium difficile–Associated Disease
Volume 116, Issue 4, Pages (April 1999)
Volume 120, Issue 7, Pages (June 2001)
Volume 129, Issue 1, Pages (July 2005)
Volume 120, Issue 2, Pages (February 2001)
Michael A. Ricci, MD, Gail Strindberg, MD, Jeffery M
Microscopic Esophageal Mucosal Injury in Nonerosive Reflux Disease
Blockade of poly(ADP-ribose) synthetase inhibits neutrophil recruitment, oxidant generation, and mucosal injury in murine colitis  Basilia Zingarelli,
Volume 122, Issue 2, Pages (February 2002)
Gastrointestinal Endoscopy  Volume 46, Issue 3, Pages (September 1997)
Volume 117, Issue 1, Pages (July 1999)
A patient with improvement of ulcerative colitis after appendectomy
Kalyana Lavu, Anil Minocha  Gastroenterology 
Esophageal variceal bleeding: Primary prophylaxis
Volume 142, Issue 7, Pages e1 (June 2012)
Volume 120, Issue 7, Pages (June 2001)
The matrix metalloproteinase inhibitor BB-94 limits expansion of experimental abdominal aortic aneurysms  David A. Bigatel, MD, James R. Elmore, MD, David.
Amebic colitis simulating ulcerative colitis
Usefulness of specific OA biomarkers, thrombin-cleaved osteopontin, in the posterior cruciate ligament OA rabbit model  S.G. Gao, L. Cheng, C. Zeng, L.C.
Eosinophilic esophagitis treated with immunotherapy to dust mites
Extensive circumferential endoscopic mucosal resection with a new rigid esophagoscope: An animal study  Raphaelle Pilloud, MD, Yves Jaquet, MD, Philippe.
Treatment of minor wounds from dermatologic procedures: A comparison of three topical wound care ointments using a laser wound model  Nathan S. Trookman,
Presentation transcript:

Experimental esophagitis induced by acid and pepsin in rabbits mimicking human reflux esophagitis  Angel Lanas*, Yolanda Royo‡, Javier Ortego§, M. Molina*, R. Sáinz*  Gastroenterology  Volume 116, Issue 1, Pages 97-107 (January 1999) DOI: 10.1016/S0016-5085(99)70233-7 Copyright © 1999 American Gastroenterological Association Terms and Conditions

Fig. 1 Surgical procedure used to perfuse AP into the esophageal lumen. Rabbits underwent surgery for placement of a plastic tube (internal diameter, 5 mm) into the lumen of the cervical esophagus. The tube was secured with surgical ligatures, tunneled, and fixed through the skin on the posterior cervical area, allowing free access to the lumen of the esophagus. Gastroenterology 1999 116, 97-107DOI: (10.1016/S0016-5085(99)70233-7) Copyright © 1999 American Gastroenterological Association Terms and Conditions

Fig. 2 Microphotograph of immunohistochemical staining with the antibody mib1, which detects the Ki67 nuclear antigen of proliferation, showing more than 5 rows of proliferating cells at the basal level. Gastroenterology 1999 116, 97-107DOI: (10.1016/S0016-5085(99)70233-7) Copyright © 1999 American Gastroenterological Association Terms and Conditions

Fig. 3 Macroscopic and microscopic scores of mucosal damage with the different perfusion regimens of 60, 45, and 30 minutes at days (A) 3 and (B) 5 (**P < 0.001 vs. other regimens; *P < 0.05 vs. 30 min/12 h). Gastroenterology 1999 116, 97-107DOI: (10.1016/S0016-5085(99)70233-7) Copyright © 1999 American Gastroenterological Association Terms and Conditions

Fig. 3 Macroscopic and microscopic scores of mucosal damage with the different perfusion regimens of 60, 45, and 30 minutes at days (A) 3 and (B) 5 (**P < 0.001 vs. other regimens; *P < 0.05 vs. 30 min/12 h). Gastroenterology 1999 116, 97-107DOI: (10.1016/S0016-5085(99)70233-7) Copyright © 1999 American Gastroenterological Association Terms and Conditions

Fig. 4 Macroscopic and microscopic scores of mucosal damage with the different perfusion regimens (60, 45, and 30 minutes) at different time intervals. (A) **P ≤ 0.01 vs. all others; φP < 0.05 vs. all microscopic scores and macroscopic scores of the 60 min/12 h regimen. (B) **P < 0.01, *P < 0.05 vs. day 1. (C) **P < 0.01, *P < 0.05 vs. days 1, 5, 7, and 20. Gastroenterology 1999 116, 97-107DOI: (10.1016/S0016-5085(99)70233-7) Copyright © 1999 American Gastroenterological Association Terms and Conditions

Fig. 4 Macroscopic and microscopic scores of mucosal damage with the different perfusion regimens (60, 45, and 30 minutes) at different time intervals. (A) **P ≤ 0.01 vs. all others; φP < 0.05 vs. all microscopic scores and macroscopic scores of the 60 min/12 h regimen. (B) **P < 0.01, *P < 0.05 vs. day 1. (C) **P < 0.01, *P < 0.05 vs. days 1, 5, 7, and 20. Gastroenterology 1999 116, 97-107DOI: (10.1016/S0016-5085(99)70233-7) Copyright © 1999 American Gastroenterological Association Terms and Conditions

Fig. 4 Macroscopic and microscopic scores of mucosal damage with the different perfusion regimens (60, 45, and 30 minutes) at different time intervals. (A) **P ≤ 0.01 vs. all others; φP < 0.05 vs. all microscopic scores and macroscopic scores of the 60 min/12 h regimen. (B) **P < 0.01, *P < 0.05 vs. day 1. (C) **P < 0.01, *P < 0.05 vs. days 1, 5, 7, and 20. Gastroenterology 1999 116, 97-107DOI: (10.1016/S0016-5085(99)70233-7) Copyright © 1999 American Gastroenterological Association Terms and Conditions

Fig. 5 Microphotographs of mild esophageal damage (low-grade esophagitis) obtained after perfusion of AP for 30 min/12 h for 7 days (H&E stain). (A) Superficial epithelial loss, basal hyperplasia, and extended papillae. (B) Extended papillae, basal hyperplasia, vasodilatation, and edema of the submucosa. Gastroenterology 1999 116, 97-107DOI: (10.1016/S0016-5085(99)70233-7) Copyright © 1999 American Gastroenterological Association Terms and Conditions

Fig. 6 Macroscopic appearance of formaldehyde-fixed esophageal specimens. (A) Mild esophagitis showing edema, hyperemia, petechia, and focal and isolated areas of submucosal hemorrhage. (B) Severe esophagitis with extensive longitudinal erosion, ulceration, and bleeding of the lower and middle esophagus. (C) Severe esophageal damage with longitudinal and confluent ulceration of the middle esophagus. Gastroenterology 1999 116, 97-107DOI: (10.1016/S0016-5085(99)70233-7) Copyright © 1999 American Gastroenterological Association Terms and Conditions

Fig. 7 Microphotographs of severe esophageal damage (high-grade esophagitis) obtained after perfusion of AP for 45 min/12 h for 5 days (H&E stain). (A) Extensive epithelial loss with intense edema and infiltration of inflammatory cells (polymorphonuclear and lymphocyte) in the mucosa and submucosa. (B) Details of specimens with ulceration and moderate infiltration of inflammatory cells. (C) Other areas with extended papillae, edema, and bleeding. Gastroenterology 1999 116, 97-107DOI: (10.1016/S0016-5085(99)70233-7) Copyright © 1999 American Gastroenterological Association Terms and Conditions